Journey Medical Corporation (DERM) earnings
DERM earnings moved a median of -1.37% by the close. Quarterly and annual DERM reports and results, each read against the price at its own news timestamp. Back to the DERM overview →
29 measured DERM earnings events.
Where these DERM earnings landedvs 27 measured DERM earnings reactions
| Middle 50% of DERM earnings reactions | -4.18% to +2.58% |
|---|---|
| Median reaction (to close) | -1.37% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 DERM earnings events with a measured close landed between -4.18% and +2.58%; 37% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Journey Medical Corp For: Jun 30 | SEC filing · Form 10-Q | -1.91% | -9.52% | |
| Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | -1.91% | -9.52% | |
| Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026 | Press release | +1.25% | -0.16% | |
| Form 10-Q Journey Medical Corp For: Mar 31 | SEC filing · Form 10-Q | +3.07% | +2.58% | |
| Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights | Press release | +3.07% | +2.58% | |
| Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026 | Press release | +0.00% | -3.85% | |
| Form 10-K Journey Medical Corp For: Dec 31 | SEC filing · Form 10-K | -1.38% | -17.87% | |
| Form 10-Q Journey Medical Corp For: Sep 30 | SEC filing · Form 10-Q | -2.97% | — | |
| Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -2.97% | — | |
| Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025 | Press release | -0.22% | -1.78% | |
| Form 10-Q Journey Medical Corp For: Jun 30 | SEC filing · Form 10-Q | -5.08% | -3.33% | |
| Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | -5.08% | -3.33% | |
| Journey Medical Corporation to Announce Second Quarter 2025 Financial Results on August 12, 2025 | Press release | — | +0.56% | |
| Form 10-Q Journey Medical Corp For: Mar 31 | SEC filing · Form 10-Q | +12.99% | +13.78% | |
| Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | Press release | +12.99% | +13.78% | |
| Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025 | Press release | -1.01% | -0.72% | |
| Form 10-K Journey Medical Corp For: Dec 31 | SEC filing · Form 10-K | -6.93% | -4.52% | |
| Form 10-Q Journey Medical Corp For: Sep 30 | SEC filing · Form 10-Q | -1.04% | -6.91% | |
| Journey Medical Corporation Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | -1.04% | -6.91% | |
| Form 10-Q Journey Medical Corp For: Jun 30 | SEC filing · Form 10-Q | +2.52% | +10.55% | |
| Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | +2.52% | +10.55% | |
| Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 | Press release | -0.20% | -2.77% | |
| Form 10-Q Journey Medical Corp For: Mar 31 | SEC filing · Form 10-Q | +3.85% | -1.37% | |
| Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights | Press release | +1.97% | +4.64% | |
| Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024 | Press release | -0.84% | -3.10% | |
| Form 10-K Journey Medical Corp For: Dec 31 | SEC filing · Form 10-K | -2.25% | -6.76% | |
| Form 10-Q Journey Medical Corp For: Sep 30 | SEC filing · Form 10-Q | +0.17% | -0.25% | |
| Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights | Press release | -4.27% | +0.27% | |
| Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023 | Press release | — | +5.61% |
Keep exploring
More DERM: analyst actions → · SEC filings → · DERM overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| BioRestorative Therapies, Inc. (BRTX) | 209 | -0.82% | 38% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 208 | -0.32% | 48% |
| Windtree Therapeutics, Inc. (WINT) | 207 | -1.40% | 27% |
| Cronos Group Inc (CRON_TSE) | 206 | +0.15% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.